Catheter Precision
VTAK
10 hedge funds and large institutions have $177K invested in Catheter Precision in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.01% less ownership
Funds ownership: 0.04% → 0.03% (-0.01%)
9% less funds holding
Funds holding: 11 → 10 (-1)
27% less capital invested
Capital invested by funds: $241K → $177K (-$64.2K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$4.57K |
| 2 |
Renaissance Technologies
New York
|
+$653 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$27.5K |
| 2 |
VF
Virtu Financial
New York
|
-$17K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$7.09K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $98.4K | -$27.5K | -337 | -21% |
|
2
Baird Financial Group
Milwaukee,
Wisconsin
| $40.7K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $11.9K | – | – | – |
|
|
4
Renaissance Technologies
New York
| $10K | +$653 | +8 | +7% |
|
5
BlackRock
New York
| $7.45K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $4.32K | +$4.57K | +56 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $3.06K | – | – | – |
|
|
HI
8
Harbour Investments
Madison,
Wisconsin
| $615 | – | – | – |
|
|
FDCDDQ
9
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $81 | – | – | – |
|
|
APC
10
Aspire Private Capital
Cornelius,
North Carolina
| $48 | – | – | – |
|
11
Wells Fargo
San Francisco,
California
| $18 | – | – | – |
|
12
Qube Research & Technologies (QRT)
London,
United Kingdom
| $2 | – | – | – |
|
|
KFI
13
Key Financial Inc
West Chester,
Pennsylvania
| $1 | – | – | – |
|
|
VF
14
Virtu Financial
New York
| – | -$17K | -196 | Closed |
|
|
TSS
15
Two Sigma Securities
New York
| – | -$7.09K | -84 | Closed |
|
VTAK Hedge Fund Activity: Q4 2023 in Review
10 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q4 2023, worth a combined $177K — down 27% from $241K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of VTAK and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, opening a new position worth an estimated $4.57K. The largest seller was Armistice Capital, cutting an estimated $27.5K.
- 10 institutional investors held Catheter Precision (VTAK) as of Q4 2023, down from 11 in Q3 2023.
- Funds reported $177K of Catheter Precision stock for Q4 2023, down 27% quarter-over-quarter.
- 1 fund opened new Catheter Precision positions in Q4 2023 and 2 closed out, a net change of -1 holder.
- The largest Catheter Precision buyer in Q4 2023 was UBS Group, an estimated $4.57K added.
- The largest Catheter Precision seller in Q4 2023 was Armistice Capital, an estimated $27.5K sold.
Based on aggregated 13F filings for Q4 2023.